Clinical Trial Update: PERS Genetic Model Assistant Decision-making System of Neoadjuvant Chemotherapy for Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update involving a PERS Genetic Model Assistant to guide neoadjuvant chemotherapy decisions in breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Shi Yanxia | Conditions: Breast Cancer Model, Effects of Chemotherapy | Phase 3 | Status: UNKNOWN